CRISPR target prediction remains blunt tool for clinical applications.
作者信息
Hodgson John
机构信息
, Cambridge, UK.
出版信息
Nat Biotechnol. 2019 Mar;37(3):204-205. doi: 10.1038/s41587-019-0057-7.
PMID:30833770
Abstract
摘要
相似文献
1
CRISPR target prediction remains blunt tool for clinical applications.
Nat Biotechnol. 2019 Mar;37(3):204-205. doi: 10.1038/s41587-019-0057-7.
2
[Nanoblades: Pseudoviral shuttles for CRISPR-CAS9 delivery].
Virologie (Montrouge). 2019 Feb 1;23(1):3-6. doi: 10.1684/vir.2019.0759.
3
[Research progress in the third-generation genomic editing technology - CRISPR/Cas9].[第三代基因组编辑技术——CRISPR/Cas9的研究进展]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2016 Oct;33(5):713-6. doi: 10.3760/cma.j.issn.1003-9406.2016.05.030.
4
The CRISPR/Cas9 Genome Editing Revolution.CRISPR/Cas9基因编辑革命
J Genet Genomics. 2016 May 20;43(5):227-8. doi: 10.1016/j.jgg.2016.05.004.
5
EPO revokes Broad's CRISPR patent.欧洲专利局撤销了博德研究所的CRISPR专利。
Nat Biotechnol. 2018 Mar 6;36(3):209. doi: 10.1038/nbt0318-209b.
6
The epigenome editors: How tools such as CRISPR offer new details about epigenetics.表观基因组编辑工具：诸如CRISPR之类的工具如何提供有关表观遗传学的新细节。
Nat Med. 2017 Aug 4;23(8):900-903. doi: 10.1038/nm0817-900.
7
Plenary Symposia.
In Vitro Cell Dev Biol Anim. 2018 Jun;54(Suppl 1):2-5. doi: 10.1007/s11626-018-0254-6.
8
Keynote Symposium.
In Vitro Cell Dev Biol Anim. 2018 Jun;54(Suppl 1):1. doi: 10.1007/s11626-018-0250-x.
9
The New Frontiers in Cancer.癌症的新前沿
Trends Cancer. 2016 Oct;2(10):533. doi: 10.1016/j.trecan.2016.10.008. Epub 2016 Oct 21.
10
Focus on CRISPR tools and therapies.
Nat Biotechnol. 2020 Jul;38(7):765. doi: 10.1038/s41587-020-0611-3.
Zotero 插件